[{"Assets_0_Q3_USD":1746237000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":113850000.0,"NetIncomeLoss_1_Q3_USD":53146000.0,"NetIncomeLoss_3_Q3_USD":139646000.0,"PaymentsOfDividendsCommonStock_3_Q3_USD":60395000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":56704000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":56539000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":55603000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":55075000.0,"StockholdersEquity_0_Q3_USD":832134000.0,"EarningsPerShareBasic_1_Q3_USD":0.96,"EarningsPerShareBasic_3_Q3_USD":2.54,"EarningsPerShareDiluted_1_Q3_USD":0.94,"EarningsPerShareDiluted_3_Q3_USD":2.47,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":675312000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":1995721000.0,"Ticker":"NUS","CIK":"1021561","name":"NU SKIN ENTERPRISES INC","OfficialName":"Nu Skin Enterprises Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2429332607.0","Country":"United States","Sector":"Health Care","Industry":"Other Pharmaceuticals","Market":"NYSE","SP500":"nan","filed":"20181108"}]